Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment
OPEN Vascular health and risk management | 5 Feb 2013
V Lukashevich, A Schweizer, JE Foley, S Dickinson, PH Groop and W Kothny
The purpose of this study was to evaluate the efficacy of vildagliptin 50 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate < 30 mL/min/1.73 m(2)) and longstanding type 2 diabetes not adequately controlled with insulin therapy, which is a difficult-to-treat population, with limited therapeutic options and a high susceptibility to hypoglycemia.
* Data courtesy of Altmetric.com